Blueprint Medicines - Stock Price History | BPMC

Historical daily share price chart and data for Blueprint Medicines since 2021 adjusted for splits. The latest closing stock price for Blueprint Medicines as of October 27, 2021 is 104.21.
  • The all-time high Blueprint Medicines stock closing price was 124.48 on December 23, 2020.
  • The Blueprint Medicines 52-week high stock price is 125.61, which is 20.5% above the current share price.
  • The Blueprint Medicines 52-week low stock price is 79.08, which is 24.1% below the current share price.
  • The average Blueprint Medicines stock price for the last 52 weeks is 97.48.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Blueprint Medicines Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 78.7505 82.1900 124.4800 48.1100 112.1500 40.00%
2019 79.4884 51.1800 101.4100 48.7000 80.1100 48.60%
2018 73.9396 80.0100 102.9500 45.5700 53.9100 -28.51%
2017 50.5752 28.9500 88.3200 28.9500 75.4100 168.84%
2016 22.6589 24.4600 38.0600 13.3400 28.0500 6.49%
2015 25.9596 18.8700 35.9200 18.5300 26.3400 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $6.072B $0.794B
Blueprint Medicines Corp is an oncology company which is engaged in developing kinase inhibitors for genomically defined cancer subsets. Blueprint Medicines Corp is based in Cambridge, MA.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $129.416B 8.62
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.526B 21.21
Biohaven Pharmaceutical Holding (BHVN) United States $9.249B 0.00
Emergent Biosolutions (EBS) United States $2.705B 6.53
Arcus Biosciences (RCUS) United States $2.404B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.873B 0.00
Myovant Sciences (MYOV) United Kingdom $1.831B 0.00
Zymeworks (ZYME) Canada $1.080B 0.00
Ambrx Biopharma (AMAM) United States $0.464B 0.00
SQZ Biotechnologies (SQZ) United States $0.372B 0.00
Enzo Biochem (ENZ) United States $0.161B 15.86